These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 30050750)

  • 21. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA CRNDE promotes tumor growth in medulloblastoma.
    Song H; Han LM; Gao Q; Sun Y
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2588-97. PubMed ID: 27383309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
    Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
    Li D; Pan Y; Huang Y; Zhang P; Fang X
    Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer.
    Hu J; Qian Y; Peng L; Ma L; Qiu T; Liu Y; Li X; Chen X
    Cell Physiol Biochem; 2018; 49(1):322-334. PubMed ID: 30138934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
    Deng R; Zhang J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway.
    Zhuang J; He S; Wang G; Wang G; Ni J; Zhang S; Ye Y; Xia W
    Oncol Res; 2018 Sep; 26(8):1257-1265. PubMed ID: 29463348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
    Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
    Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
    Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
    Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
    Zhang Y; Wang Y; Liu M
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LOXL1-AS1 promotes cell proliferation in hepatocellular carcinomathrough miR-1224-5p/ITPRIPL2/AKT axis.
    Chen T; Zeng S; Liu Q; Chen Y; Lu J
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):45-50. PubMed ID: 37715432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.